NEW YORK (GenomeWeb News) – GeneNews today said that it has signed an agreement with Centcor granting the drug firm selected access to research from its osteoarthritis genomic biomarker program.
Heiner Dreissman, interim CEO and lead director of GeneNews, said in a statement that the firm’s Sentinel Principle, its biomarker-discovery platform, was validated around osteoarthritis. He added that the collaboration is “a source of non-dilutive funding that will contribute to our commercialization efforts.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.